| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
24,740,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.35 - $0.35 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bullock Francis J |
Director |
– • – |
2010-09-30 |
4 |
A |
$0.32 |
$1,875 |
D/D |
5,859 |
21,226 |
|
- |
|
| Tuck Alan W |
Director |
– • – |
2010-09-30 |
4 |
A |
$0.32 |
$1,500 |
D/D |
4,688 |
16,797 |
|
- |
|
| Bullock Francis J |
Director |
– • – |
2010-07-02 |
4 |
A |
$0.46 |
$1,875 |
D/D |
4,076 |
15,367 |
|
- |
|
| Mcnamara Pamela W |
Director |
– • – |
2010-07-02 |
4 |
A |
$0.46 |
$1,000 |
D/D |
2,174 |
8,494 |
|
- |
|
| Tuck Alan W |
Director |
– • – |
2010-07-02 |
4 |
A |
$0.46 |
$1,500 |
D/D |
3,261 |
12,109 |
|
- |
|
| Mcnamara Pamela W |
Director |
– • – |
2010-04-01 |
4 |
A |
$0.55 |
$1,000 |
D/D |
1,818 |
6,320 |
|
- |
|
| Tuck Alan W |
Director |
– • – |
2010-04-01 |
4 |
A |
$0.55 |
$1,500 |
D/D |
2,727 |
8,848 |
|
- |
|
| Scotland Richard A |
Senior VP, Regulatory Affairs |
• – – |
2010-02-09 |
4 |
B |
$1.08 |
$15,982 |
I/I |
14,798 |
14,798 |
1.99 |
- |
|
| Scotland Richard A |
Senior VP, Regulatory Affairs |
• – – |
2010-01-19 |
4 |
S |
$1.13 |
$16,648 |
I/I |
(14,798) |
0 |
|
- |
|
| Lfb Biotechnologies S.a.s.u. |
Director by Deputization |
– • • |
2010-01-06 |
4 |
OE |
$2.24 |
$12,749,996 |
D/D |
5,299,071 |
21,299,906 |
|
- |
|
| Mcnamara Pamela W |
Director |
– • – |
2009-12-31 |
4 |
A |
$0.75 |
$1,000 |
D/D |
1,333 |
4,502 |
|
- |
|
| Bullock Francis J |
Director |
– • – |
2009-12-31 |
4 |
A |
$0.75 |
$1,875 |
D/D |
2,500 |
7,882 |
|
- |
|
| Tuck Alan W |
Director |
– • – |
2009-12-31 |
4 |
A |
$0.75 |
$1,500 |
D/D |
2,000 |
6,121 |
|
- |
|
| Geraghty James A |
Director |
– • – |
2009-12-31 |
4 |
A |
$0.75 |
$3,000 |
D/D |
4,000 |
19,025 |
|
- |
|
| Scotland Richard A |
Senior VP, Regulatory Affairs |
• – – |
2009-11-02 |
4/A |
D |
$1.21 |
$7,754 |
D/D |
(6,408) |
17,587 |
|
- |
|
| Scotland Richard A |
Senior VP, Regulatory Affairs |
• – – |
2009-11-02 |
4/A |
A |
$1.21 |
$16,170 |
D/D |
13,364 |
23,995 |
|
- |
|
| Green John B |
Senior VP and CFO |
• – – |
2009-11-02 |
4/A |
D |
$1.21 |
$6,760 |
D/D |
(5,587) |
24,413 |
|
- |
|
| Green John B |
Senior VP and CFO |
• – – |
2009-11-02 |
4/A |
A |
$1.21 |
$18,814 |
D/D |
15,549 |
30,000 |
|
- |
|
| Cox Geoffrey F |
President, CEO and Chairman |
• • – |
2009-11-02 |
4/A |
D |
$1.21 |
$13,544 |
D/D |
(11,193) |
80,411 |
|
- |
|
| Cox Geoffrey F |
President, CEO and Chairman |
• • – |
2009-11-02 |
4/A |
A |
$1.21 |
$42,696 |
D/D |
35,286 |
91,604 |
|
- |
|
| Meade Harry |
SVP, Transgenic Research |
• – – |
2009-11-02 |
4/A |
D |
$1.21 |
$6,679 |
D/D |
(5,520) |
25,737 |
|
- |
|
| Meade Harry |
SVP, Transgenic Research |
• – – |
2009-11-02 |
4/A |
A |
$1.21 |
$18,638 |
D/D |
15,403 |
31,257 |
|
- |
|
| Woloshen Daniel S |
Senior VP and General Counsel |
• – – |
2009-11-02 |
4/A |
D |
$1.21 |
$5,066 |
D/D |
(4,187) |
19,215 |
|
- |
|
| Woloshen Daniel S |
Senior VP and General Counsel |
• – – |
2009-11-02 |
4/A |
A |
$1.21 |
$15,834 |
D/D |
13,086 |
23,402 |
|
- |
|
| Green John B |
Senior VP and CFO |
• – – |
2009-11-02 |
4 |
A |
$1.21 |
$16,604 |
D/D |
13,722 |
28,173 |
|
- |
|
209 Records found
|
|
Page 1 of 9 |
|
|
